Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190
CHAPTER 1.Industry Overview of Virtual Clinical Trials
1.1.Definition and Scope
1.1.1.Definition of Virtual Clinical Trials
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Virtual Clinical Trials Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Virtual Clinical Trials Market By Study Design
1.2.3.Virtual Clinical Trials Market By Indication
1.2.4.Virtual Clinical Trials Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Virtual Clinical Trials Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Virtual Clinical Trials Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2019
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2.R&D Status and Application Source of Virtual Clinical Trials Major Manufacturers in 2019
CHAPTER 5.Virtual Clinical Trials Market By Study Design
5.1.Introduction
5.2.Virtual Clinical Trials Revenue By Study Design
5.2.1.Virtual Clinical Trials Revenue (US$ Mn) and Forecast, By Study Design, 2016-2027
5.2.2.Interventional
5.2.2.1.Interventional Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.Observational
5.2.3.1.Observational Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4.Expanded Access
5.2.4.1.Expanded Access Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6.Virtual Clinical Trials Market Revenue By Indication
6.1.Introduction
6.2.Virtual Clinical Trials Revenue (US$ Mn) By Indication
6.2.1.Virtual Clinical Trials Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
6.2.2.Oncology
6.2.2.1.Oncology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.Cardiovascular
6.2.3.1.Cardiovascular Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4.Others
6.2.4.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7.North America Virtual Clinical Trials Market By Country
7.1.North America Virtual Clinical Trials Overview
7.2.U.S.
7.2.1.U.S. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016-2027
7.2.2.U.S. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
7.3.Canada
7.3.1.Canada Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016-2027
7.3.2.Canada Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
7.4.North America PEST Analysis
CHAPTER 8.Europe Virtual Clinical Trials Market By Country
8.1.Europe Virtual Clinical Trials Market Overview
8.2.U.K.
8.2.1.U.K. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016-2027
8.2.2.U.K. Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.3.Germany
8.3.1.Germany Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016-2027
8.3.2.Germany Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.4.France
8.4.1.France Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016-2027
8.4.2.France Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.5.Spain
8.5.1.Spain Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016-2027
8.5.2.Spain Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.6.Rest of Europe
8.6.1.Rest of Europe Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016-2027
8.6.2.Rest of Europe Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.7.Europe PEST Analysis
CHAPTER 9.Asia Pacific Virtual Clinical Trials Market By Country
9.1.Asia Pacific Virtual Clinical Trials Market Overview
9.2.China
9.2.1.China Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
9.2.2.China Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
9.3.Japan
9.3.1.Japan Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
9.3.2.Japan Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
9.4.India
9.4.1.India Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
9.4.2.India Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
9.5.Australia
9.5.1.Australia Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
9.5.2.Australia Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
9.6.South Korea
9.6.1.South Korea Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
9.6.2.South Korea Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
9.7.Rest of Asia-Pacific
9.7.1.Rest of Asia-Pacific Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
9.7.2.Rest of Asia-Pacific Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
9.8.Asia Pacific PEST Analysis
CHAPTER 10.Latin America Virtual Clinical Trials Market By Country
10.1.Latin America Virtual Clinical Trials Market Overview
10.2.Brazil
10.2.1.Brazil Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
10.2.2.Brazil Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
10.3.Mexico
10.3.1.Mexico Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
10.3.2.Mexico Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
10.4.Rest of Latin America
10.4.1.Rest of Latin America Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 – 2027
10.4.2.Rest of Latin America Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 – 2027
10.5.Latin America PEST Analysis
CHAPTER 11.Middle East & Africa Virtual Clinical Trials Market By Country
11.1.Middle East & Africa Virtual Clinical Trials Market Overview
11.2.Saudi Arabia
11.2.1.Saudi Arabia Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
11.2.2.Saudi Arabia Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
11.3.UAE
11.3.1.UAE Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
11.3.2.UAE Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 - 2027
11.4.Rest of Middle East & Africa
11.4.1.Rest of Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Study Design, 2016 - 2027
11.4.2.Rest of Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Mn) and Forecast By Indication, 2016 – 2027
11.5.Middle East & Africa PEST Analysis
CHAPTER 12.Player Analysis Of Virtual Clinical Trials
12.1.Virtual Clinical Trials Market Company Share Analysis
12.2.Competition Matrix
12.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2.New Product Launches and Product Enhancements
12.2.3.Mergers And Acquisition In Global Virtual Clinical Trials Market
12.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13.COMPANY PROFILE
13.1.ICON plc
13.1.1.Company Snapshot
13.1.2.Business Overview
13.1.3.Financial Overview
13.1.3.1.Revenue (US$ Mn), 2019
13.1.3.2.ICON plc 2019 Virtual Clinical Trials Business Regional Distribution
13.1.4.Product/ Service and Specification
13.1.5.Recent Developments & Business Strategy
13.1.6.Manufacturing Plant Footprint Analysis
13.2.Parexel International
13.3.IQVIA
13.4.Covance Inc.
13.5.PRA Health Sciences
13.6.LEO Innovation Lab
13.7.Medidata Solutions
13.8.Oracle Corporation
13.9.CRF Health
13.10.Clinical Ink, Inc.
13.11.Medable, Inc.
13.12.Others
